Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An optimal design for screening trials

Y G Wang1, D H Leung

  • 1CSIRO Mathematical and Information Sciences, Cleveland, Queensland, Australia. You-Gan.Wang@marine.csiro.au

Biometrics
|April 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment of benign acquired esophagorespiratory fistula with through-the-clip device: a report of 2 cases and literature review].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2026
Same author

[Investigation and analysis on relationship between sickness presenteeism, occupational stress, fatigue accumulation and work functioning impairment in nurses].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026
Same author

[Research progresses on phosphate homeostasis and phosphate toxicity in type 2 diabetes mellitus and its complications].

Zhonghua nei ke za zhi·2025
Same author

[Establishment of a novel Bama minipig model of laryngopharyngeal reflux via endoscopic cricopharyngeal myotomy].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2024
Same author

[A single-center analysis of pathogenic bacteria distribution and drug resistance in bacterial bloodstream infections among patients with hematological diseases].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same author

[Genotype and epidemiological characteristics of human metapneumovirus among hospitalized cases of acute respiratory infection in children in Changchun City, Jilin Province from 2019 to 2023].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2024
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces a sequential design for drug testing, optimizing patient sample sizes. The new method significantly reduces the number of patients needed to identify effective therapeutic agents while controlling error rates.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacological Research

Background:

  • Previous research (Yao, Begg, & Livingston, 1996) focused on fixed group sizes for testing therapeutic agents.
  • Identifying promising agents efficiently requires minimizing patient sample sizes.

Purpose of the Study:

  • To develop an optimal sequential design for testing multiple therapeutic agents.
  • To minimize the total number of patients (sample size) required in clinical trials.
  • To establish a strategy that allows for early acceptance or rejection of agents.

Main Methods:

  • Utilized Markov decision processes to formulate an optimal strategy.
  • Minimized sample size under constraints of false positive and false negative error probabilities.

Related Experiment Videos

  • Employed Lagrangian multipliers to represent the costs associated with different error types.

    • Main Results:

    • Developed a sequential design enabling early decisions on therapeutic agents.
    • Demonstrated substantial reductions in required patient sample sizes through numerical studies.
    • The optimal strategy effectively balances error rates and sample size efficiency.

    Conclusions:

    • Sequential designs offer significant advantages over fixed group sizes in therapeutic agent testing.
    • The proposed Markov decision process approach provides an efficient method for sample size minimization.
    • This strategy can lead to faster identification of effective treatments with fewer patients.